3OG7 | Transferase Transferase Inhibitor | date | Aug 16, 2010 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
title | B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 | ||||||||||||||
authors | Y.Zhang, K.Y.Zhang, C.Zhang | ||||||||||||||
compound | source | ||||||||||||||
Molecule: Akap9-Braf Fusion Protein Chain: A, B Fragment: Kinase Domain (Unp Residues 1175-1446) Synonym: Proto-Oncogene B-Raf, P94, V-Raf Murine Sarcoma Vi Oncogene Homolog B1; Ec: 2.7.11.1 Engineered: Yes Mutation: Yes |
Organism_scientific: Homo Sapiens Organism_common: Human Organism_taxid: 9606 Gene: Braf, Braf1, Rafb1 Expression_system: Escherichia Coli Expression_system_taxid: 562 | ||||||||||||||
symmetry | Space Group: P 21 21 21 |
| |||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 2.45 Å | ||||||||||||
ligand | 032 BindingDB | enzyme | Transferase E.C.2.7.11.1 BRENDA | ||||||||||||
note | 3OG7 (Molecule of the Month:pdb195) | ||||||||||||||
Gene Ontology |
| ||||||||||||||
Primary reference | Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma., Bollag G, Hirth P, Tsai J, Zhang J, Ibrahim PN, Cho H, Spevak W, Zhang C, Zhang Y, Habets G, Burton EA, Wong B, Tsang G, West BL, Powell B, Shellooe R, Marimuthu A, Nguyen H, Zhang KY, Artis DR, Schlessinger J, Su F, Higgins B, Iyer R, D'Andrea K, Koehler A, Stumm M, Lin PS, Lee RJ, Grippo J, Puzanov I, Kim KB, Ribas A, McArthur GA, Sosman JA, Chapman PB, Flaherty KT, Xu X, Nathanson KL, Nolop K, Nature. 2010 Sep 7. PMID:20823850 |
Data retrieval |
View 3OG7 in 3D |
Visual 3D analysis of 3OG7 |
Structure-derived information |
Sequence-derived information |
Other resources with information on 3OG7 |
Movements, Movies and Images |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |